SynthesisMedicine2018

Comparison of dipeptidyl peptidase-4 inhibitors and pioglitazone combination therapy versus pioglitazone monotherapy in type 2 diabetes: A system review and meta-analysis.

Ben Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.